| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $42.3M | +30.8% |
| SG&A Expense | $18.8M | +46.2% |
| Operating Income | -$61.1M | -35.2% |
| Interest Expense | $581K | — |
| Income Tax | $0 | — |
| Net Income | -$52.4M | -22.2% |
| EPS (Basic) | -$1.08 | -1.9% |
| EPS (Diluted) | -$1.08 | -1.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $66.9M | -48.6% |
| Short-term Investments | $176.6M | +271.8% |
| Current Assets | $246.6M | +36.8% |
| Total Assets | $310.1M | +57.8% |
| Current Liabilities | $13.0M | +66.0% |
| Long-term Debt | $29.9M | — |
| Total Liabilities | $43.2M | +452.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$43.1M | -22.5% |
| Investing Cash Flow | -$171.7M | -538.1% |
| Financing Cash Flow | $151.8M | +3784.1% |
| Stockholders' Equity |
| $267.0M |
| +41.4% |